CNN Chief Medical Correspondent Dr. Sanjay Gupta interviewed Dr. Doris Trauner, lead researcher of CMCR's study on childhood autism. The clinical trial is examining how CBD can affect the brains of children with autism. Read the story with video clips from the interview here.
PDF of the 2022 CMCR Symposium Program
Day 1: Thursday, April 21, 2022
8:00-8:05 Welcome from the CMCR Director, Igor Grant, MD - LINK to VIDEO
2022 CMCR Symposium Awards
8:05-8:40 Daniele Piomelli, PhD, MD (h.c.) - 2022 CMCR Pioneer in Medicinal Cannabis Research Award
Presentation of Award and Keynote Address - Trekking on the Endocannabinoid Trail - LINK to VIDEO
This award honors leaders in cannabis and cannabinoid research conducting basic and translational research of cannabinoids, other constituents of cannabis, and the endocannabinoid system. The recipient’s work has led to significant advancements in our understanding of the mechanism and physiological effects of cannabinoids and related compounds.
8:40-9:15 Donald Abrams, MD - 2022 CMCR Award for Advancing Cannabis and Cannabinoids as Therapeutics
Presentation of Award and Keynote Address - Conducting Clinical Cannabis Research Tribulations and Trials - LINK to VIDEO
This award honors those whose work has led to significant changes in our knowledge of or an expansion to the therapeutic use of cannabis and cannabinoid-based medicines. Recipients come from a diverse array of backgrounds, including drug development, medicine, public policy, and advocacy.
9:15-9:20 5-minute break
2022 Award Recipients: Daniele Piomelli, PhD and Donald Abrams, MD
2019 Award Recipients: Raphael Mechoulam, PhD and Geoffrey Guy, MD
9:55-10:00 5-minute break
CMCR Special Lecture
10:00-10:20 Raphael Mechoulam, PhD - Endogenous Anandamide-like Compounds - LINK to VIDEO
10:20-10:30 Q&A moderated by Igor Grant, MD
Panel 1: Update on Federal activities affecting cannabis research - LINK to VIDEO
10:30-11:55 Panel discussion and Q&A moderated by Steve Gust, PhD, Advisor to CMCR
The invited Federal stakeholders will discuss future directions in regulatory policy related to medicinal cannabis, funding for medicinal cannabis research, and access to cannabis and cannabinoids for research purposes.
Panelists:
Trelaine Ito, Deputy Appropriations Director and Legislative Assistant to Senator Schatz - "Congressional Actions Related to Cannabis Affecting Research"
David Shurtleff, PhD, National Center on Complementary and Integrative Health (NCCIH), NIH - "Cannabinoid Research at NIH"
Cassandra Taylor, PhD, Center for Drug Evaluation and Research, FDA - "FDA Role in Regulation of Cannabis"
Richard (Rik) Kline, PhD, Chief, Chemistry and Pharmaceutics Branch, NIDA - "Role of the NIDA Drug Supply Program in Providing Cannabis Products for Research"
11:55-12:00 5-minute break
12:00-1:00 Poster Session - LINK to pre-recorded VIDEOS
Day 2: Friday, April 22, 2022
State of the Science Lecture Series
Neuroprotective Effects of Cannabis and Cannabinoids: Evidence from PTSD - LINK to VIDEO
8:00-8:15 Leah Mayo, PhD - Protective Effects of Elevated Anandamide During Stress Exposure
8:15-8:30 Christine Rabinak, PhD - Cannabinoid Modulation of Corticolimbic Activation to Threat
8:30-8:45 Marcel Bonn-Miller, PhD - Cannabis and PTSD
8:45-8:55 Q&A moderated by Arpi Minassian, PhD
8:55-9:00 5-minute break
Cannabinoids and COVID-19 - LINK to VIDEO
9:00-9:15 Michelle Sexton, ND - Cannabis and COVID-19 Infection
9:15-9:30 José Alexandre S. Crippa, MD, PhD - Cannabidiol (CBD) and COVID-19
9:30-9:40 Q&A moderated by Ajay Bharti, MD
FAAH inhibitor in the Treatment of Substance Use Disorders - LINK to VIDEO
9:40-9:55 Deepak D'Souza, MD - Blunting Cannabis Use Disorder by Targeting the Endocannabinoid System
9:55-10:00 Q&A moderated by Giordano de Guglielmo, PharmD, PhD
10:00-10:05 5-minute break
Panel 2: Promoting industry and university partnership to enhance cannabis research - LINK to VIDEO
10:05-10:55 Panel discussion and Q&A moderated by Igor Grant, MD
Panelists will be invited to discuss partnerships between universities and the cannabis industry, providing models and exploring synergies.
Panelists: Mahmoud ElSohly PhD, Josh Hoerner PhD, Mark Ware MBBS, MRCP, MSc ICD.D
10:55-11:00 5-minute break
Panel 3: Early experience of federally-licensed cannabis growers - LINK to VIDEO
11:00-11:45 Panel discussion and Q&A moderated by Tom Marcotte, PhD
Representatives from DEA-licensed cannabis growers will discuss their early experience and future goals to produce cannabis and cannabinoid-based products for research.
Panelists: Justin Abril (Royal Emerald Pharmaceuticals), Steve Groff MD (Groff North America), George Hodgin MBA (Biopharmaceutical Research Company), Sue Sisley MD (Scottsdale Research Institute)
11:45-12:00 Closing Remarks from the CMCR Director, Igor Grant, MD - LINK to VIDEO
LINK to 2022 CMCR Symposium Sponsors
The Center for Medicinal Cannabis Research (CMCR) hosted a virtual, two-day symposium on October 12-13, 2023 highlighting the state of science in medicinal cannabis research. Whereas the majority of current research focuses on delta-9-THC and cannabidiol, the 2023 CMCR Symposium highlighted emerging clinical and translational research on the "other" constituents of cannabis (minor cannabinoids, terpenes, and flavonoids) and the entourage effect.
Day 1: Thursday, October 12, 2023
8:00-8:05 Welcome from the CMCR Director, Igor Grant, MD
2023 CMCR Symposium Awards
8:05-8:40 Marilyn Huestis, AB, MS, PhD - 2023 CMCR Pioneer in Medicinal Cannabis Research Award
This award honors leaders in cannabis and cannabinoid research conducting basic and translational research of cannabinoids, other constituents of cannabis, and the endocannabinoid system. The recipient’s work has led to significant advancements in our understanding of the mechanism and physiological effects of cannabinoids and related compounds.
8:40-9:15 Margaret Haney, PhD - 2023 CMCR Award for Advancing Cannabis and Cannabinoids as Therapeutics
This award honors those whose work has led to significant changes in our knowledge of or an expansion to the therapeutic use of cannabis and cannabinoid-based medicines. Recipients come from a diverse array of backgrounds, including drug development, medicine, public policy, and advocacy.
9:15-9:20 5-minute break
9:20-9:55 Moderated panel discussion and Q&A with 2023 CMCR Symposium Award Recipients - LINK to VIDEO
Videos of congratulations from 2022 Award Recipients - LINK to VIDEO from Dr. Daniele Piomelli & LINK to VIDEO from Dr. Donald Abrams
9:55-10:00 5-minute break
CMCR Special Lectures
10:20-10:30 Q&A moderated by JH Atkinson, MD
10:50-10:55 Q&A discussion moderated by JH Atkinson, MD
10:55-11:00 5-minute break
Panel 1: Update on Federal activities affecting cannabis research
11:00-11:55 Panel discussion and Q&A moderated by Steve Gust, PhD, Advisor to CMCR
Panelists:
David Shurtleff, PhD, Deputy Director, National Center for Complementary and Integrative Health
Cassandra Taylor, PhD, Botanical Products, Center for Drug Evaluation and Research, US Food and Drug Administration
Richard (Rik) Kline, PhD, Chief, Chemistry and Pharmaceutics Branch, NIDA
11:55-12:00 Introduction to the poster session
12:00-1:00 Poster Session - LINK to VIDEOS
Day 2: Friday, October 13, 2023
State of the Science Lecture Series
The Entourage: Minor Cannabinoids, Terpenes, and Flavonoids
8:00-8:05 Welcome
8:20-8:35 Ryan Vandrey, PhD - Behavioral Pharmacology of D-Limonene and THC - LINK to VIDEO
8:55-9:00 5-minute break
9:30-10:00 Q&A moderated by Ziva Cooper, PhD and Patrick Still, PhD
10:00-10:05 5-minute break
Panel 2: Use of minor cannabinoids, terpenes, and flavonoids in the community
10:05-10:55 Panel discussion and Q&A moderated by Igor Grant, MD
Panelists:
Sherry Yafai, MD, Providence St. John's Medical Center
Bonni Goldstein, MD, Medical Director, CannaCenters
Michelle Sexton, ND, UC San Diego
Dale Gieringer, PhD, California NORML
10:55-11:00 5-minute break
11:00-11:20 Linda Hill, MD, MPH - The State of Cannabis: A Survey of 5,000 Californians - LINK to VIDEO
11:20-11:25 Q&A discussion moderated by David Grelotti, MD
11:45-11:50 Q&A discussion moderated by David Grelotti, MD
11:50-12:00 Closing Remarks from the CMCR Director, Igor Grant, MD
Please direct questions to
Page 10 of 23